Medworxx
Solutions Inc. ("Medworxx") (TSX VENTURE: MWX)
today announced a partnership with Kurt Salmon to use the Medworxx
Patient Flow Platform to conduct audits of healthcare organizations in
France as part of their management consulting process.
Kurt Salmon will use the Medworxx Appropriate Length of Stay Audit
(“ALSA”) in combination with their own audit processes and
methodologies. The ALSA uses the proven Medworxx software as an audit
and diagnostic solution, prior to hospitals implementing the solution
operationally. Management consulting companies and hospital support
agencies are able to use Medworxx to rapidly unlock unique patient flow
data, providing visibility into patient flow issues in the hospitals
that they provide services to.
Similar audits have proven to be effective in identifying hospital
patient flow barriers and delays, and thus effective in enabling
Medworxx to penetrate new markets. For example, two UK audit sites – The
Royal Liverpool and Broadgreen University Hospitals, and South Tees
Hospitals NHS Foundation Trust – recently became users of the Medworxx
Patient Flow solution, marking an initial successful entry to the UK
market. Medworxx and its consulting partners have conducted multiple
audits internationally in 2013, in locations including the UK,
Australia, and Canada.
“There is a definite need for the Medworxx Patient Flow solution in
France,” said Didier Guidoni, Partner, Welfare and Healthcare, Kurt
Salmon. “We look forward to working with Medworxx to bring their
solution to market.”
“We are excited to be entering the France market, which is almost four
times the size of the Canadian market based on number of beds,” said Dan
Matlow, President and CEO, Medworxx. “We believe our solution is well
suited for the France market and are encouraged that an organization
such as Kurt Salmon has recognized the value of the unique information
that can be obtained through the use of Medworxx and our ALSA program.
We look forward to working with Kurt Salmon.”
About Medworxx
Medworxx delivers health information solutions to over 350 hospitals
internationally; including Canada, United States and United Kingdom.
Medworxx helps hospitals meet patient flow challenges, and requirements
in compliance and education. Medworxx Clinical Criteria – flagship of
Medworxx Patient Flow that includes electronic bed board and independent
assessment components – currently serves over 35% of the acute care beds
in Canada. Founded in 2004, Medworxx is based in Toronto, ON, and
publicly traded on the TSX Venture Exchange: MWX.
Visit: http://www.medworxx.com/
About Kurt Salmon
Kurt Salmon is a global management consulting firm of 1400 consultants
across 19 countries and four continents. Member of the Management
Consulting Group, Kurt Salmon is a unique and global company which
delivers to its clients highly specialized and sectorial services in
strategy, organization and management.
Disclaimer
The statements made in this press release may contain forward-looking
statements that may involve a number of risks and uncertainties. Actual
events or results could differ materially from the company’s
expectations and projections. The TSX Venture Exchange has not reviewed
this press release and neither approved nor disapproved the information
contained in this press release.
Copyright Business Wire 2013